EMA and NICE appraisal processes for cancer drugs: Current status and uncertainties

Dickson, R., Boland, A., Duarte, R. orcid.org/0000-0001-6485-7415 et al. (16 more authors) (2018) EMA and NICE appraisal processes for cancer drugs: Current status and uncertainties. Applied Health Economics and Health Policy, 16 (4). pp. 429-432. ISSN 1175-5652

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Dates:
  • Published (online): 28 May 2018
  • Published: August 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > ScHARR - Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
NATIONAL INSTITUTE FOR HEALTH RESEARCH14/25/02
Depositing User: Symplectic Sheffield
Date Deposited: 15 Jun 2018 14:37
Last Modified: 15 Sep 2021 07:54
Status: Published
Publisher: Springer Nature
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40258-018-0393-7
Related URLs:

Export

Statistics